Cattle Healthcare Market Size, Share and Global Trend By Product (Vaccines, Pain Management, Antibiotics, Nutritious Feed), By End-user (Dairy Farms, Veterinary Hospitals, Others), and Regional Forecast, 2024-2032

Cattle healthcare is one of the prominent aspects of animal husbandry since it has direct co-relation with productivity and outcome from animal farming. A well-planned cattle health routine of schedule can prevent and reduce the risk of prominent cattle diseases such as bovine tuberculosis, anthrax, brucellosis, rabies, and others. According to Agriculture Victoria, Australia, an estimated 79.8% of cows causes milk fever just within one day of calving. The diseases such as milk fever directly affect on milk production of cow.

Global Cattle Healthcare market growth is being driven by the increasing prevalence of chronic diseases, increasing adoption of animal farming for higher revenues & productivity, and budding emphasis on cattle health. According to TB Epidemiology Report 2017 published by Animal and Plant Health Agency, UK, the number of cows affected by bovine tuberculosis grew from 3,753 in 2016 to 3,816 in 2017, which accounted for an estimated 1.7% of growth as compared to the previous year. Also, certain advantages offered by cattle healthcare products such as improved cattle immunity as well as higher production are expected to boost the demand for global cattle healthcare market during the forecast period.

On the flip side, poor implementation and reluctance of government authorities to conduct veterinary health programs in emerging nations are restraining the growth of the global cattle healthcare market.

Key Players Covered

The major companies covered in the global Cattle Healthcare market report include Ceva, Zoetis, Boehringer Ingelheim International GmbH, Merck & Co., Inc., Elanco, Abaxis, Virbac, HESKA AG, BioZyme, Inc., Hyalogic, Parker Laboratories, Inc., Jorgensen Labs Agri-Pro Enterprises of Iowa, Inc., and others.

SEGMENTATION

As per the current cattle healthcare market trends, veterinary hospitals and clinics among the end user are anticipated to register a higher market share in the global cattle healthcare market due to the various government animal welfare organizations have issued guidelines for safety practices and standards to be implemented in veterinary hospitals and clinics.

Key Insights

• Prevalence of Cattle Diseases


• Key mergers and acquisitions

Regional Analysis

The global cattle healthcare market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global cattle healthcare market in 2018 owing to growth in cattle farming and emphasis on higher production. Along with this, upsurge in the prevalence of diseases in livestock, high investment & expenditure in the animal healthcare in the developed countries and technologically advanced disease detection system in the cattle healthcare are some of the factors projecting the growth of the global cattle healthcare market during the forecast period. The Asia Pacific and Middle East & Africa hold enormous potential for the advancement of the global cattle healthcare market owing to rising ownership of livestock, growing prevalence of disease outbreaks and spreading awareness by government authorities for veterinary health. Combined with this, increasing business demand for animal farming in emerging nations such as India and China is projected to increase the demand for cattle healthcare during the forecast period.

Cattle Healthcare Industry Developments

• In June 2018 Elanco Animal Health launched new respiratory PRRS vaccine
• In January 2018 Elanco announced global agreement with Ab E discovery for new technology.
• In September 2018, Boehringer Ingelheim launched Bovalto Respi Intranasal is a new respiratory vaccine for active immunization of cattle against the viruses Parainfluenza 3 Virus (PI3V) and Bovine Respiratory Syncytial Virus (BRSV).